Cellular ontogeny and hierarchy influence the reprogramming efficiency of human B cells into induced pluripotent stem cells

Stem Cells

Volumn 34, Issue 3, 2016, Pages 581-587

  Muñoz López, Álvaro ^a   Van Roon, Eddy H J ^b   Romero Moya, Damià ^a   López Millan, Belén ^a   Stam, Ronald W ^b   Colomer, Dolors ^c   Nakanishi, Mahito ^d   Bueno, Clara ^a   Menendez, Pablo ^a,e  

^a UNIVERSITY OF BARCELONA   (Spain)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c HOSPITAL CLÍNIC   (Spain)

^d NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^e INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Fetal liver; Hierarchy; Human B cells; Human B cell progenitors; Ig gene rearrangements; Induced pluripotent stem cells; Ontogeny; OSKM; Sendai virus

Indexed keywords

KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2; HISTONE LYSINE METHYLTRANSFERASE; KRUPPEL LIKE FACTOR; POU5F1 PROTEIN, HUMAN; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOPOIESIS; NUCLEAR REPROGRAMMING; ONTOGENY; PLURIPOTENT STEM CELL; PRE B LYMPHOCYTE; ANIMAL; CELL CULTURE TECHNIQUE; CYTOLOGY; FETUS BLOOD; GENE VECTOR; GENETICS; INDUCED PLURIPOTENT STEM CELL; MOUSE;

ANIMALS; B-LYMPHOCYTES; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLULAR REPROGRAMMING; FETAL BLOOD; GENETIC VECTORS; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; OCTAMER TRANSCRIPTION FACTOR-3; PROTO-ONCOGENE PROTEINS C-MYC; SOXB1 TRANSCRIPTION FACTORS;

EID: 84959441063     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2303     Document Type: Article

References (32)

1. Wu SM, Hochedlinger K,. Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol 2011; 13: 497-505.
2. Aasen T, Raya A, Barrero MJ, et al., Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotec 2008; 26: 1276-1284.
3. Sun N, Panetta NJ, Gupta DM, et al., Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci USA 2009; 106: 15720-15725.
4. Ji H, Zhang X, Oh S, et al., Dynamic transcriptional and epigenomic reprogramming from pediatric nasal epithelial cells to induced pluripotent stem cells. J Allergy Clin Immunol 2015; 135: 236-244.
5. Merling RK, Sweeney CL, Choi U, et al., Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34 + cells. Blood 2013; 121: e98-107.
6. Ramos-Mejia V, Montes R, Bueno C, et al., Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34 + progenitors. PLoS One 2012; 7: e35824.
7. Loh YH, Agarwal S, Park IH, et al., Generation of induced pluripotent stem cells from human blood. Blood 2009; 113: 5476-5479.
8. Okita K, Yamakawa T, Matsumura Y, et al., An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells 2013; 31: 458-466.
9. Seki T, Yuasa S, Oda M, et al., Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 2010; 7: 11-14.
10. Staerk J, Dawlaty MM, Gao Q, et al., Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell 2010; 7: 20-24.
11. Bueno C, Sardina JL, Di Stefano B, et al., Reprogramming human B-cells into induced pluripotent stem cells and its enhancement by C/EBPalpha. Leukemia 2015.
12. Kleger A, Mahaddalkar PU, Katz SF, et al., Increased reprogramming capacity of mouse liver progenitor cells, compared with differentiated liver cells, requires the BAF complex. Gastroenterology 2012; 142: 907-917.
13. Liebau S, Mahaddalkar PU, Kestler HA, et al., A hierarchy in reprogramming capacity in different tissue microenvironments: What we know and what we need to know. Stem Cells Dev 2013; 22: 695-706.
14. Blelloch R, Wang Z, Meissner A, et al., Reprogramming efficiency following somatic cell nuclear transfer is influenced by the differentiation and methylation state of the donor nucleus. Stem Cells 2006; 24: 2007-2013.
15. Kim JB, Zaehres H, Wu G, et al., Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 2008; 454: 646-650.
16. Eminli S, Foudi A, Stadtfeld M, et al., Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Gen 2009; 41: 968-976.
17. Nishimura K, Sano M, Ohtaka M, et al., Development of defective and persistent Sendai virus vector: A unique gene delivery/expression system ideal for cell reprogramming. J Biol Chem 2011; 286: 4760-4771.
18. Okano S, Yonemitsu Y, Nagata S, et al., Recombinant Sendai virus vectors for activated T lymphocytes. Gene Ther 2003; 10: 1381-1391.
19. Ramos-Mejia V, Fernandez AF, Ayllon V, et al., Maintenance of human embryonic stem cells in mesenchymal stem cell-conditioned media augments hematopoietic specification. Stem Cells Dev 2012; 21: 1549-1558.
20. Sanchez L, Gutierrez-Aranda I, Ligero G, et al., Maintenance of human embryonic stem cells in media conditioned by human mesenchymal stem cells obviates the requirement of exogenous basic fibroblast growth factor supplementation. Tissue Eng Part C, Methods 2012; 18: 387-396.
21. Ramos-Mejia V, Munoz-Lopez M, Garcia-Perez JL, et al., iPSC lines that do not silence the expression of the ectopic reprogramming factors may display enhanced propensity to genomic instability. Cell Res 2010; 20: 1092-1095.
22. van Dongen JJ, Langerak AW, Bruggemann M, et al., Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17: 2257-2317.
23. Romero-Moya D, Bueno C, Montes R, et al., Cord blood-derived CD34 + hematopoietic cells with low mitochondrial mass are enriched in hematopoietic repopulating stem cell function. Haematologica 2013; 98: 1022-1029.
24. Bueno C, Roldan M, Anguita E, et al., Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease. Haematologica 2014; 99: 1168-1175.
25. Tan KY, Eminli S, Hettmer S, et al., Efficient generation of iPS cells from skeletal muscle stem cells. PLoS One 2011; 6: e26406.
26. Kim JB, Greber B, Arauzo-Bravo MJ, et al., Direct reprogramming of human neural stem cells by OCT4. Nature 2009; 461: 649-643.
27. Bloushtain-Qimron N, Yao J, Shipitsin M, et al., Epigenetic patterns of embryonic and adult stem cells. Cell Cycle 2009; 8: 809-817.
28. Chin MH, Mason MJ, Xie W, et al., Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009; 5: 111-123.
29. Doi A, Park IH, Wen B, et al., Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 2009; 41: 1350-1353.
30. Kim K, Doi A, Wen B, et al., Epigenetic memory in induced pluripotent stem cells. Nature 2010; 467: 285-290.
31. Polo JM, Liu S, Figueroa ME, et al., Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotec 2010; 28: 848-855.
32. Kulis M, Merkel A, Heath S, et al., Whole-genome fingerprint of the DNA methylome during human B cell differentiation. Nat Genet 2015; 47: 746-756.